CSL invests $313m to bulk up flu, COVID-19 mRNA tech

The biotech giant wants to beef up its mRNA capabilities and has signed a deal with Nasdaq-listed company, Arcturus.

Related Keywords

Monash ,South Australia ,Australia ,Melbourne ,Victoria ,Paul Mckenzie ,Jefferies David Stanton ,Steve Marlow ,Monash University ,University Of Queensland ,Mental Health ,Florey Institute Of Neuroscience ,Diabetes Institute ,Astrazeneca ,Hudson Institute ,University Of Melbourne ,St Vincent Institute ,Florey Institute ,Baker Heart ,David Stanton ,